Financhill
Back

FibroGen Vs. Arbutus Biopharma Industry Stock Comparison

Buy
52

FGEN
FibroGen

Last Price:
0.39
Seasonality Move:
88.99%
Sell
36

ABUS
Arbutus Biopharma

Last Price:
3.51
Seasonality Move:
15.21%
Buy
52
FibroGen (FGEN) is a Buy

Is FibroGen a Buy, Sell or Hold?

  • The current FibroGen [FGEN] share price is $0.39. The Score for FGEN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • FGEN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy, Sell or Hold?

  • The current Arbutus Biopharma [ABUS] share price is $3.46. The Score for ABUS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • ABUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FGEN Stock Price Chart

What is FibroGen's stock price today?

  • The FibroGen share price today is $0.39
    The current trend is relatively stagnant and FGEN is experiencing buying pressure, which is a positive indicator for future bullish movement.

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

  • The Arbutus Biopharma share price today is $3.46
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing selling pressure, which indicates risk of future bearish movement.

FGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 57.98 Buy
Chaikin Money Flow: 1244178 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.3 - 0.36) Buy
Bollinger Bands (100): (0.24 - 0.78) Sell

ABUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 30.71 Sell
Chaikin Money Flow: -475329 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.61 - 4.03) Sell
Bollinger Bands (100): (3.57 - 4.13) Sell

FGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.36 Buy
20-day SMA: 0.33 Buy
50-day SMA: 0.36 Buy
200-day SMA: 1.03 Sell
8-day EMA: 0.35 Buy
20-day EMA: 0.34 Buy
50-day EMA: 0.38 Buy
200-day EMA: 1.23 Sell

ABUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.56 Sell
20-day SMA: 3.76 Sell
50-day SMA: 3.9 Sell
200-day SMA: 3.37 Buy
8-day EMA: 3.56 Sell
20-day EMA: 3.71 Sell
50-day EMA: 3.82 Sell
200-day EMA: 3.43 Buy

FibroGen Earnings Growth & FGEN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.70 per share, and an increase next year of $0.48 per share.

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.

FibroGen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arbutus Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):